Quantum-Si (Nasdaq: QSI) will participate in the H.C. Wainwright 28th Annual Global Investment Conference at the Lotte New York Palace Hotel, September 14–16, 2026. On September 15, 2026, CEO Jeff Hawkins and CFO Jeff Keyes will hold one-on-one meetings and Hawkins will join a 1:30 PM ET fireside chat, with a live and archived webcast available in the Investors section of the Quantum-Si website.
Loading...
Loading translation...
Positive
None.
Negative
None.
Market Context
QSI’s platform record includes a listed -6.35% 24-hour reaction to its August 13 earnings announceme...
Analysis
QSI’s platform record includes a listed -6.35% 24-hour reaction to its August 13 earnings announcement. The conference appearance adds investor-access context, while risk context characterized short positioning as low.
Key Figures
Conference edition:28th annualConference dates:September 14-16, 2026Meeting date:September 15, 2026+1 more
4 metrics
Conference edition28th annualH.C. Wainwright Global Investment Conference
Conference datesSeptember 14-16, 2026H.C. Wainwright Global Investment Conference
Meeting dateSeptember 15, 2026One-on-one meetings with company executives
Quantum-Si granted 427,636 restricted stock units to new employees.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Pattern Detected
The stock declined after four of five recent news events; the largest listed move was -6.35% after the August 13 earnings report.
Key Terms
proteomics, single-molecule protein sequencing
2 terms
proteomicstechnical
"a proteomics technology company redefining protein analysis"
Proteomics is the large-scale study of all the proteins produced by a cell, tissue or organism, like taking a full inventory and watching how the workforce and machines inside a factory behave. For investors, proteomics matters because it helps identify drug targets, disease indicators and responses to treatments—information that can speed development, reduce risk, guide partnerships and reveal new commercial opportunities in biotech and diagnostics.
single-molecule protein sequencingtechnical
"through single-molecule protein sequencing"
Single-molecule protein sequencing is a laboratory method that reads the exact order of building blocks in a single protein molecule, similar to reading letters in a word rather than averaging many copies. For investors it matters because it promises far more sensitive and precise detection of disease markers, faster drug discovery and highly personalized diagnostics, which could create new markets or disrupt existing lab testing and therapeutics businesses.
BRANFORD, Conn., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Quantum-Si Incorporated (Nasdaq: QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics technology company redefining protein analysis through single-molecule protein sequencing, today announced that it will be participating in the H.C. Wainwright 28th Annual Global Investment Conference taking place at the Lotte New York Palace Hotel, September 14-16, 2026.
Jeff Hawkins, President and Chief Executive Officer, and Jeff Keyes, Chief Financial Officer, will be taking one-on-one meetings throughout the day on Tuesday, September 15, 2026, and Jeff Hawkins will participate in a fireside chat on the same day at 1:30 PM Eastern Time.
A live and archived webcast of the event will be available in the “Investors” section of the Quantum-Si website under Events & Presentations.
About Quantum-Si Incorporated Quantum-Si is transforming proteomics with a benchtop platform that brings single-molecule protein analysis to every lab, everywhere. The Company’s platform enables real-time kinetic-based detection and allows researchers to move beyond traditional, multistep workflows and directly access dynamic, functional protein insights with unparalleled resolution. By making protein analysis simpler, faster, and more informative, Quantum-Si is accelerating proteomic discoveries to improve the way we live. Learn more at quantum-si.com or follow us on LinkedIn or X.
Investors & Media Jeff Keyes Chief Financial Officer ir@quantum-si.com
FAQ
When will Quantum-Si (QSI) appear at the H.C. Wainwright 28th Annual Global Investment Conference in 2026?
Quantum-Si will participate in the H.C. Wainwright 28th Annual Global Investment Conference from September 14–16, 2026. According to Quantum-Si, its key activities, including one-on-one meetings and a fireside chat, are scheduled for Tuesday, September 15, 2026 at the Lotte New York Palace Hotel.
What is Quantum-Si (QSI) presenting at the H.C. Wainwright Global Investment Conference on September 15, 2026?
On September 15, 2026, Quantum-Si’s CEO Jeff Hawkins will participate in a fireside chat at 1:30 PM Eastern Time. According to Quantum-Si, Hawkins and CFO Jeff Keyes will also conduct one-on-one investor meetings throughout the day at the conference.
How can investors access the Quantum-Si (QSI) webcast from the H.C. Wainwright 2026 conference?
Investors can access a live and archived webcast of Quantum-Si’s conference appearance via the Investors section of the Quantum-Si website. According to Quantum-Si, the webcast will be listed under the Events & Presentations page for convenient on-demand viewing.
Who will represent Quantum-Si (QSI) at the H.C. Wainwright 28th Annual Global Investment Conference?
Quantum-Si will be represented by Jeff Hawkins, President and Chief Executive Officer, and Jeff Keyes, Chief Financial Officer. According to Quantum-Si, both executives will participate in one-on-one meetings, and Hawkins will lead a fireside chat session on September 15, 2026.
Where is the H.C. Wainwright 28th Annual Global Investment Conference featuring Quantum-Si (QSI) being held?
The H.C. Wainwright 28th Annual Global Investment Conference will take place at the Lotte New York Palace Hotel. According to Quantum-Si, the event runs from September 14–16, 2026, with the company’s primary activities occurring on September 15, 2026 at this New York venue.
